Navigation Links
Cell phone-cancer link found by Tel Aviv University scientist
Date:2/14/2008

An Israeli scientist, Dr. Siegal Sadetzki, has found a link between cell phone usage and the development of tumors.

Dr. Sadetzki, a physician, epidemiologist and lecturer at Tel Aviv University, published the results of a study recently in the American Journal of Epidemiology, in which she and her colleagues found that heavy cell phone users were subject to a higher risk of benign and malignant tumors of the salivary gland.

Those who used a cell phone heavily on the side of the head where the tumor developed were found to have an increased risk of about 50% for developing a tumor of the main salivary gland (parotid), compared to those who did not use cell phones.

The fact that the study was done on an Israeli population is significant. Says Sadetzki, Unlike people in other countries, Israelis were quick to adopt cell phone technology and have continued to be exceptionally heavy users. Therefore, the amount of exposure to radiofrequency radiation found in this study has been higher than in previous cell phone studies.

This unique population has given us an indication that cell phone use is associated with cancer, adds Sadetzki, whose study investigated nearly 500 people who had been diagnosed with benign and malignant tumors of the salivary gland.

Controlled Study Reveals Link

The studys subjects were asked to detail their cell phone use patterns in terms of how frequently they used one, and the average length of calls. They were compared to a sample of about 1,300 healthy control subjects.

The study also found an increased risk of cancer for heavy users who lived in rural areas. Due to fewer antennas, cell phones in rural areas need to emit more radiation to communicate effectively.

Sadetzki predicts that, over time, the greatest effects will be found in heavy users and children.

While anecdotal evidence has been substantial, the consistency of the results of this s
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. One Species Genome Found Within Another
2. National Patient Safety Foundation Partners with Vocera Communications
3. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
4. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
5. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
6. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
7. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
8. The Tug McGraw Foundation Announces 2007 Fundraising Gala
9. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
10. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
11. Big Relief for Tiny Itch Mites Found in All Natural Spray Remedy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell phone-cancer link found by Tel Aviv University scientist
Cell phone-cancer link found by Tel Aviv University scientist
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...ute asthma attacks be causing the very thing it ai...ard School of Public Health and Brigham and Women’...known as beta-agonists in asthmatics. Beta-agonist... used to relieve acute asthma attacks. The drugs c...
... do prevent the onset of Parkinson’s disease. The ...o regularly take nonsteroidal// anti-inflammatory ...n those who did not take the drugs. Parkinson’s di... neurons in the brain. The result is a loss in mot...
...researchers say mindful meditation can have a posi...t the University of //Wisconsin, determined the pr...side of the brain and has a healthy effect. The re...rk environment with healthy employees. During an e...
...killers during pregnancy increases the risk of mis...hich include// aspirin and ibuprofen, are some of ...regnant women. Doctors interviewed 1,055 pregnant ...heir pregnancy. The participants were asked questi...
Other Medicine News:
(Date:10/6/2008)...ore than 60 percent of moderate to severe patients...cent achieved endoscopic remission at Week 10,in d...he American College,of Gastroenterology (ACG) Annu...ewswire/ -- UCB today presented data from a,large,...ement in Crohn,s,disease (CD) with a biologic comp...
(Date:10/6/2008)...EATTLE, Oct. 6 /- Dendreon ...call today, Monday, October 6, 2008 at 9:00 AM,ET ...analysis of its IMPACT,(IMmunotherapy for Prostate...linical trial of PROVENGE(R) (sipuleucel-T), the C...rapy for the treatment of advanced prostate,cancer...
(Date:10/3/2008)...urlington County, New Jersey is the newest study s... -- The Children,s Hospital,of Philadelphia today ...The,National Children,s Study. Children,s Hospital...data collection in Burlington County, New,Jersey. ...Health., Investigators anticipate approximately 1...
(Date:10/2/2008)...udy to support Urgent PC clinical success and expa...coverage, MINNEAPOLIS, Oct. 2 /PRNewswire-FirstCa... the enrollment of the first patients in a new,ran...its FDA cleared Urgent,PC neuromodulation system f...oms of urinary urgency, urge incontinence and freq...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement 3A Australia New Z 7377 1 CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement 3A Australia New Z 7377 2Ortho McNeil Neurologics to Appeal Patent Ruling on RAZADYNE 28R 29 7373 1Ortho McNeil Neurologics to Appeal Patent Ruling on RAZADYNE 28R 29 7373 2Ortho McNeil Neurologics to Appeal Patent Ruling on RAZADYNE 28R 29 7373 3Medivation Announces Participation in Upcoming Conferences 7371 1Medivation Announces Participation in Upcoming Conferences 7371 2Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL 28R 29 D Dimer Assay 7367 1Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL 28R 29 D Dimer Assay 7367 2
...ted against CTCL, PTCL and Ovarian Cancers,-, BRAN...-- CuraGen,Corporation , a clinical-stage biopharm...oday an update on the clinical development,program...bitor, and,reported updated results suggesting cli...ell lymphoma (CTCL), peripheral T-cell,lymphoma (P...
...SS WIRE)--Jun 12, 2007 - Critical,Therapeutics, In...of data from a pivotal Phase III clinical trial of...in the June 2007 issue of the,Journal of Asthma. Z...inistration (FDA) on May 30, 2007. Critical Therap..., L.P. (DEY), expects to,begin marketing ZYFLO CR ...
Other Medicine Technology:CuraGen Presents Update on Clinical Development Program for,Belinostat 2CuraGen Presents Update on Clinical Development Program for,Belinostat 3CuraGen Presents Update on Clinical Development Program for,Belinostat 4CuraGen Presents Update on Clinical Development Program for,Belinostat 5CuraGen Presents Update on Clinical Development Program for,Belinostat 6CuraGen Presents Update on Clinical Development Program for,Belinostat 7CuraGen Presents Update on Clinical Development Program for,Belinostat 8Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
Facilitates intubation of tracheal tubes.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: